NATASHA HORNER: Open Payments
NPI 1962711325 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,715 in 96 payments from 23 companies in 2025. Trend: 2023 $28 · 2024 $1,161 · 2025 $1,715
Food & beverage: $1,715
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $220 |
| Amgen Inc. | 17 | $215 |
| Novo Nordisk Inc | 13 | $191 |
| Corium, LLC | 8 | $153 |
| Bard Peripheral Vascular, Inc. | 1 | $146 |
| AstraZeneca Pharmaceuticals LP | 7 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $135 |
| PFIZER INC. | 6 | $111 |
| Antares Pharma, Inc. | 3 | $63 |
| Ferring Pharmaceuticals Inc. | 1 | $37 |
Products named: MOUNJARO, Azstarys, Venovo, AIRSUPRA, Kerendia, Ozempic, OTEZLA, KRYSTEXXA.
Industry payments across AL — which companies pay providers there.
